Age-Related Macular Degeneration
The leading cause of blindness in older adults — and a rare case where a supplement genuinely works
What it is
Age-related macular degeneration damages the macula — the small central part of the retina that handles detailed vision — and it is the leading cause of severe sight loss in older adults in high-income countries. It destroys CENTRAL vision, leaving peripheral vision intact, which means it does not cause total blindness but does take away reading, driving and the ability to recognise a face. There are two kinds and the distinction matters enormously. DRY AMD is gradual and by far the more common. WET AMD, in which abnormal blood vessels grow and leak beneath the retina, is much less common, progresses over DAYS TO WEEKS, and is the one that is treatable — and urgently so.
Why it matters
Because wet AMD is a race, and most people do not know they are in it. Anti-VEGF injections into the eye are genuinely transformative — they stop and often reverse the vision loss of wet AMD — and their effectiveness depends heavily on how quickly they are started. The warning sign is specific and is easy to miss: straight lines start to look BENT or WAVY (metamorphopsia), or a blurred or dark patch appears in the centre of vision. That symptom needs assessment within days, not at your next routine appointment. And this is also one of the very few places in the entire BioSignal library where a SUPPLEMENT GENUINELY WORKS — the AREDS2 formulation slows progression in people who already have intermediate AMD. It is a rare and welcome finding, and it comes with two hard limits that are routinely ignored in the marketing.
What BioSignal knows about treating this
What works for Age-Related Macular Degeneration
BioSignal’s clinical summary, most important first.
- STOP SMOKING — the single largest modifiable risk factor, by a wide margin, and the most useful thing anyone can do about AMD
- IF STRAIGHT LINES START TO BEND OR WAVE, SEEK ASSESSMENT WITHIN DAYS — that is the sign of wet AMD, and anti-VEGF injections work far better when started early. This symptom is easy to dismiss and it is the whole difference
- ANTI-VEGF INJECTIONS for wet AMD — genuinely transformative, stopping and often reversing vision loss. The injections are into the eye, which everyone finds appalling to contemplate and which is entirely tolerable in practice
- AREDS2 SUPPLEMENTS if you have INTERMEDIATE AMD — this is a rare case where a supplement genuinely works: the AREDS2 formulation (vitamins C and E, zinc, copper, lutein and zeaxanthin) slows progression to advanced disease. But read the two limits below, because they are routinely ignored
- AREDS2 LIMIT ONE: it is NOT a preventive. There is no evidence it helps people who do not already have intermediate AMD, and it is widely sold to people who do not have the disease at all
- AREDS2 LIMIT TWO: the ORIGINAL AREDS formula contained BETA-CAROTENE, which INCREASES LUNG CANCER RISK IN SMOKERS AND EX-SMOKERS. It was removed in AREDS2 for exactly that reason. If you smoke or used to, do not take a beta-carotene-containing eye formula
- Use the Amsler grid regularly if you have early or intermediate AMD — it is how you catch conversion to wet AMD in time
- Eat leafy greens and oily fish; manage blood pressure and cholesterol
- Low-vision rehabilitation — magnifiers, lighting, technology. Under-referred, and it restores a great deal of independence
Signal Records relevant to this condition
Interventions and contributing factors — some of these records describe a cause rather than a cure. The rating shown is BioSignal’s confidence in that Signal Record, not a claim about how well it treats this condition. Open any of them for the full evidence.
- ZincHigh confidence
Strong evidence where there is deficiency or a specific indication. No benefit in replete people — including for testosterone — and excess causes copper deficiency.
- Vitamin CHigh confidence
Does not prevent colds — one of the best-tested negatives in nutrition. Shortens them slightly, but only if you were already taking it. Megadoses are mostly excreted: absorption saturates around 200 mg/day. Genuinely useful for iron absorption, and genuinely essential — scurvy is still real.
- Omega-3 Fatty AcidsModerate confidence
Lowers triglycerides, and reduces preterm birth in pregnancy. Routine fish oil does NOT prevent cardiovascular disease, cancer or dementia in the general population. High-dose omega-3 increases atrial fibrillation risk — a real harm most bottles do not mention.
- AlcoholHigh confidence
A Group 1 carcinogen with dose-dependent harms. The heart-protection belief does not survive the methods designed to test it. Cutting back helps, even without quitting.
New to this? Read these first
How this usually unfolds
- Recognize risk factors
- Get diagnosed
- Track key biomarkers
- Lifestyle first
- Evidence-based treatment
- Long-term monitoring
Who is at risk
- Age — the dominant factor
- SMOKING — by far the largest modifiable risk factor, roughly doubling to quadrupling risk
- Family history and genetics
- European ancestry
- Cardiovascular risk factors: hypertension, high cholesterol, obesity
- Diet low in leafy green vegetables and oily fish
- Prolonged ultraviolet and light exposure
How it's diagnosed
AMD is diagnosed on examination of the retina, supported by OCT imaging, which shows the layers of the retina in cross-section and reveals the fluid that indicates WET AMD. The single most useful self-monitoring tool is the AMSLER GRID — a simple square of graph paper with a central dot. Someone with early or intermediate AMD should look at it regularly, one eye at a time: if the lines start to bend, wave, or disappear, that is the symptom of conversion to wet AMD, and it needs assessing within days.
Key biomarkers
Lifestyle
Explore this condition across BioSignal
Related Foundations
Related Signal Records
Related body systems
Frequently asked questions
Does lutein — or any eye supplement — actually work?
This is one of the very few places in the whole of BioSignal where the answer to 'does the supplement work' is YES — and the yes comes with two limits that the marketing ignores completely. The AREDS2 formulation (vitamins C and E, zinc, copper, lutein and zeaxanthin) DOES slow progression in people who already have INTERMEDIATE age-related macular degeneration. That is a real, randomized, replicated finding. The first limit: there is no evidence it does anything for people who do NOT already have intermediate AMD — it is not a preventive, and it is sold in enormous quantities to people with perfectly healthy eyes. The second limit is a safety one and it matters: the ORIGINAL AREDS formula contained beta-carotene, which INCREASES LUNG CANCER RISK IN SMOKERS AND FORMER SMOKERS. It was removed for AREDS2. If you smoke or used to, check the label.
What is the difference between dry and wet AMD?
DRY AMD is the common form — a gradual thinning and degeneration of the macula, progressing slowly over years, and at present without a treatment that reverses it. WET AMD is much less common and is caused by abnormal, leaky blood vessels growing beneath the retina. It progresses over DAYS TO WEEKS rather than years, and it is the one that can be treated — anti-VEGF injections into the eye stop it and often reverse the vision loss. That is why the distinction is not academic: dry AMD is monitored, and wet AMD is a race. Anyone with dry AMD can convert to wet, which is what the Amsler grid is for.
When should I worry about my central vision?
When STRAIGHT LINES START TO BEND. This is the symptom that matters, it is specific, and it is easy to dismiss. Door frames, window frames, the lines on a page, the edge of a table — if they begin to look wavy, kinked or distorted, or if a blurred or dark patch appears in the middle of your vision, that suggests conversion to WET AMD and it needs assessing within DAYS, not weeks. Anti-VEGF treatment works, and it works substantially better when started early. Check each eye separately — with both eyes open, the good one compensates and hides the problem completely.
Will I go completely blind?
No — and this is worth saying clearly, because the fear is enormous and the reality, while serious, is not that. AMD attacks the MACULA, which handles central, detailed vision. It leaves peripheral vision intact. So AMD takes away reading, driving, and the ability to recognise faces, which is a profound loss and should not be minimised — but it does not produce total darkness. People with advanced AMD retain navigational vision. Low-vision rehabilitation — magnifiers, lighting, screen technology — restores a great deal of independence and is consistently under-referred.
What is the single most useful thing I can do?
Stop smoking, and it is not close. Smoking is by far the largest modifiable risk factor for AMD, raising risk several-fold, and stopping reduces it. After that: use an Amsler grid if you have intermediate AMD, so that if you convert to the wet form you catch it within days rather than months; take AREDS2 supplements if — and only if — you actually have intermediate AMD; eat leafy greens and oily fish; and manage your blood pressure and cholesterol, because AMD shares its risk factors with cardiovascular disease.
Evidence summary
Age-related macular degeneration is the leading cause of severe visual impairment in older adults in high-income countries. Smoking is the principal modifiable risk factor. The AREDS and AREDS2 randomized trials established that a specific antioxidant and zinc formulation reduces progression to advanced AMD in individuals with INTERMEDIATE AMD or advanced disease in one eye; there is no evidence of benefit in people without intermediate AMD, and the supplements are widely marketed to that population regardless. The original AREDS formulation contained beta-carotene, which increases lung cancer incidence in current and former smokers; AREDS2 substituted lutein and zeaxanthin for this reason. Anti-VEGF intravitreal therapy is highly effective in neovascular ('wet') AMD, halting and frequently reversing visual loss, with outcomes strongly dependent on prompt initiation; metamorphopsia (distortion of straight lines) is the characteristic warning symptom and warrants assessment within days. Amsler grid self-monitoring is recommended for those at risk of conversion. There is currently no established treatment that reverses geographic atrophy in dry AMD.
References & sources
- AREDS and AREDS2 randomized controlled trials
- NICE NG82 — Age-related macular degeneration: diagnosis and management
- Randomized trials of anti-VEGF therapy in neovascular AMD
- Trials of beta-carotene supplementation and lung cancer incidence in smokers (ATBC, CARET)
Educational information — not medical advice
Is this condition page clear, accurate, and useful? Your feedback shapes what we review next.
Give feedback